Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Furoate MDI in Children with Persistent Asthma
NCT01502371Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Jan 2012
- Primary completion
- Jan 2015
- Modality
- Orthosteric Ligands
01
Overview
Phase 2, randomised, double-blind trial of mometasone in asthma (5 arms), sponsored by Organon & Co. Primary endpoint: Percent Predicted Morning Forced Expiratory Volume in 1 Second at 12 weeks. Started Jan 2012; status: completed.
02
Drugs
mometasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01502371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01502371.